FDA recently issued draft guidance, entitled “Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements.” The guidance was issued to clarify when a change in a medical device product warrants a recall. Additionally, the guidance distinguishes and defines a product enhancement from a product recall. FDA is accepting comments until May 23, 2013. To read the full draft guidance, click here. To read a related article, click here. Need help with a medical device submission? Please contact us at 317-899-9341 to help with your submissions.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.